Angiotensin converting enzyme inhibitors and the risk of lung cancer

被引：0
|
作者：
Hicks, Blanaid [1 ,2 ,3 ]
Filion, Kristan B. [2 ,3 ]
Yin, Hui [2 ]
Sakr, Lama [4 ]
Udell, Jacob A. [5 ]
Azoulay, Laurent [3 ,4 ]
机构：
[1] Queens Univ Belfast, Belfast, Antrim, North Ireland
[2] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] Jewish Gen Hosp, Montreal, PQ, Canada
[5] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1013
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [1] Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
    Hicks, Blanaid M.
    Filion, Kristian B.
    Yin, Hui
    Sakr, Lama
    Udell, Jacob A.
    Azoulay, Laurent
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [2] Evaluation of Treatment With Angiotensin Converting Enzyme Inhibitors (ACEIs) and the Risk of Lung Cancer (ERACER)
    Anderson, Jeffrey L.
    Knowlton, Kirk U.
    Muhlestein, Joseph B.
    Bair, Tami L.
    Lappe, Donald L.
    Le, Viet T.
    Biswas, Santanu
    Horne, Benjamin D.
    CIRCULATION, 2019, 140
  • [3] Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence
    Khosravian, Maryam
    Momenzadeh, Mahnaz
    Koosha, Farzad
    Alimohammadi, Niloufar
    Kianpour, Neda
    IMMUNOPATHOLOGIA PERSA, 2022, 8 (01):
  • [4] Inhibitors of angiotensin-I-converting enzyme and risk of cancer
    Sattar, N
    McMillan, DC
    LANCET, 1998, 352 (9134): : 1151 - 1151
  • [5] Angiotensin converting enzyme inhibitors and risk of lung cancer: A nested case-control study
    Kristensen, Kasper Bruun
    Hicks, Blanaid
    Azoulay, Laurent
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 193 - 194
  • [6] Angiotensin converting enzyme inhibitors and risk of lung cancer A systematic review and meta-analysis
    Batais, Mohammed
    Almigbal, Turky
    Alotaibi, Khalid
    Alodhayani, Abdulaziz
    Alkhushail, Abdullah
    Altheaby, Abdulrahman
    Alhantoushi, Mashhor
    Alsaad, Saad
    Al Dalbhi, Sultan
    Alghamdi, Yasser
    MEDICINE, 2021, 100 (17) : E25714
  • [7] Angiotensin converting enzyme inhibitors for cancer treatment?
    Lindberg, H
    Nielsen, D
    Jensen, BV
    Eriksen, J
    Skovsgaard, T
    ACTA ONCOLOGICA, 2004, 43 (02) : 142 - 152
  • [8] Lung cancer risk and the inhibitors of angiotensin-converting enzyme: A mini-review of recent evidence
    Asgharpour, Masoumeh
    Kalan, Mohammad Ebrahimi
    Mirhashemi, Seyed Hadi
    Alirezaei, Amirhesam
    IMMUNOPATHOLOGIA PERSA, 2019, 5 (02):
  • [9] Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer
    Helgeson, Scott A.
    Waddle, Mark R.
    Burnside, Rebecca C.
    Debella, Yalew T.
    Lee, Augustine S.
    Burger, Charles D.
    Li, Zhuo
    Johnson, Patrick W.
    Patel, Neal M.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (09) : 607 - 613
  • [10] Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders
    Williams, Lana J.
    Pasco, Julie A.
    Kessing, Lars V.
    Quirk, Shae E.
    Fernandes, Brisa S.
    Berk, Michael
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (04) : 250 - 252
12345